Gene Therapy Manufacturing Workshop
Sponsored by Brammer Bio and MaxCyte
GENE THERAPY MANUFACTURING WORKSHOP
Strategies for BioManufacturing Viral-based Gene Therapy Vectors – Early-Stage Development Through Clinical Production
Welcome Remarks / Introduction:
Robert Preti, Ph.D., Chairman, Alliance for Regenerative Medicine (ARM); President, PCT, A Caladrius Company; SVP, Manufacturing and Technical Operations, Caladrius Biosciences
Chair:
Jessica Carmen, Ph.D., Director of Business Development, Cellular Therapy Partnerships, MaxCyte
Speakers:
James Brown, Ph.D., VP, Corporate Development, Aldevron
Matthew Caple, VP, Site Operations, Brammer Bio
Mike Kelly, Director, Asset Leadership and Portfolio Management, Gene Therapy, Biogen
Michael Roberts, Ph.D., Chief Scientific Officer, Synpromics
Видео Gene Therapy Manufacturing Workshop канала Alliance for Regenerative Medicine
GENE THERAPY MANUFACTURING WORKSHOP
Strategies for BioManufacturing Viral-based Gene Therapy Vectors – Early-Stage Development Through Clinical Production
Welcome Remarks / Introduction:
Robert Preti, Ph.D., Chairman, Alliance for Regenerative Medicine (ARM); President, PCT, A Caladrius Company; SVP, Manufacturing and Technical Operations, Caladrius Biosciences
Chair:
Jessica Carmen, Ph.D., Director of Business Development, Cellular Therapy Partnerships, MaxCyte
Speakers:
James Brown, Ph.D., VP, Corporate Development, Aldevron
Matthew Caple, VP, Site Operations, Brammer Bio
Mike Kelly, Director, Asset Leadership and Portfolio Management, Gene Therapy, Biogen
Michael Roberts, Ph.D., Chief Scientific Officer, Synpromics
Видео Gene Therapy Manufacturing Workshop канала Alliance for Regenerative Medicine
Показать
Комментарии отсутствуют
Информация о видео
25 октября 2016 г. 1:39:45
01:16:18
Другие видео канала
![Panel: When Does Investing in Cell and Gene Therapy Make Business Sense?](https://i.ytimg.com/vi/XciYH0FiuAY/default.jpg)
![Downstream Processing Challenges in Cell Therapy Manufacturing](https://i.ytimg.com/vi/g15N5HOG5ow/default.jpg)
![Gene Therapy -- The time is now: Nick Leschly at TEDxBoston](https://i.ytimg.com/vi/Ez560GnkSrE/default.jpg)
![AAV Vector Manufacturing and Analytics](https://i.ytimg.com/vi/cz_D_etMR0E/default.jpg)
![Panel: Cell Therapy Infrastructure & Manufacturing Requirements for Commercialization](https://i.ytimg.com/vi/quVKkF2SHkQ/default.jpg)
![Network Security 101: Full Workshop](https://i.ytimg.com/vi/E03gh1huvW4/default.jpg)
![Translating Stem Cell Therapies: From the Lab to Patients 2019](https://i.ytimg.com/vi/vvK_YmoQITc/default.jpg)
![K. I. Berns - Evolution of AAV Vector for Gene Therapy](https://i.ytimg.com/vi/seQcF7MQ6_Y/default.jpg)
![Basics of AAV Gene Therapy](https://i.ytimg.com/vi/p-nwUpPZF70/default.jpg)
![Webinar: Manufacturing Challenges Facing Cell and Gene Therapy](https://i.ytimg.com/vi/XEJvo0MeX5g/default.jpg)
![Standardized AAV Viral Vector and Plasmid Manufacturing and Analytics](https://i.ytimg.com/vi/rjHOb-f7nvo/default.jpg)
![Virology Lectures 2018 #24: Viral Gene Therapy](https://i.ytimg.com/vi/rcKWb9u15Ho/default.jpg)
![Panel: Gene Therapy Manufacturing](https://i.ytimg.com/vi/DFHTu0OPftY/default.jpg)
![Therapeutic antibody research: Discovery to functional assays [WEBINAR]](https://i.ytimg.com/vi/vO2-2HnSDdM/default.jpg)
![Readiness Strategies for Cell Therapy Commercial Manufacturing Workshop](https://i.ytimg.com/vi/7RHMlzLNrQI/default.jpg)
![Am I still lactose tolerant? - Lactose Gene Therapy Update](https://i.ytimg.com/vi/aoczYXJeMY4/default.jpg)
![Robert Kiyosaki 2019 - The Speech That Broke The Internet!!! KEEP THEM POOR!](https://i.ytimg.com/vi/azq0S0DKS50/default.jpg)
![The Gene Editing Revolution](https://i.ytimg.com/vi/FoYdgAI7x2Y/default.jpg)
![Large-Scale Production of Plasmid DNA & mRNA to Support Therapeutic & Vaccine Development](https://i.ytimg.com/vi/qHhor-iQFAE/default.jpg)
![Retinal Gene Therapy 2018 at Ophthalmology Innovation Summit Retina - OIS](https://i.ytimg.com/vi/7l4XADK13M4/default.jpg)